The yeast cwh36⌬ mutant was identified in a screen for yeast mutants exhibiting a Vma ؊ phenotype suggestive of loss of vacuolar proton-translocating ATPase (VATPase) activity. The mutation disrupts two genes, CWH36 and a recently identified open reading frame on the opposite strand, YCL005W-A. We demonstrate that disruption of YCL005W-A is entirely responsible for the Vma 
V-ATPases 1 are highly conserved proton pumps responsible for acidification of multiple organelles, including the Golgi apparatus, endosomes, and lysosomes, in all eukaryotic cells (1, 2) . All V-ATPases are multisubunit complexes comprised of a peripheral sector, V 1 , attached to a membrane sector, V 0 . In yeast cells, the V 1 sector contains eight different subunits, and the V 0 sector contains five subunits; all of these subunits have homologs in other eukaryotic cells (1, 2) . Genetic deletion of any V-ATPase subunit results in a well defined set of growth defects in yeast, including sensitivity to elevated pH and calcium concentrations, inability to grow on non-fermentable carbon sources, and sensitivity to a variety of heavy metals (3, 4) . This Vma Ϫ growth phenotype has been invaluable in determining the subunit composition of the yeast V-ATPase and in assessing the level of V-ATPase function in various mutants, and it has largely driven the emergence of yeast as the model system of choice in many studies of eukaryotic V-ATPases (5-7).
Although V-ATPase subunit composition is very similar among eukaryotes, highly purified preparations of the Manduca sexta and bovine chromaffin granule V-ATPases both contain membrane proteins of 9 -10 kDa that had not been observed in other systems, including yeast (8, 9) . This protein associated tightly with the V 0 sector in both preparations and appeared to be present at a comparable stoichiometry with the other V-ATPase subunits, prompting the investigators to name it the "e" subunit. However, it was impossible to determine whether these proteins played a critical role in V-ATPase function or were "accessory" proteins involved in assembly or regulation in an organelle-and/or species-specific manner. In fact, the bovine protein (8) showed limited homology to the yeast Vma21 protein, which is an endoplasmic reticulum protein essential for V-ATPase assembly (10) . This suggested that higher eukaryotes had evolved a version of Vma21p that might play a similar role in assembly but remained attached to the assembled enzyme.
We screened a library of yeast deletion strains for mutants exhibiting the Vma Ϫ phenotype characteristic of loss of VATPase activity. 2 One mutant, cwh36⌬, exhibited a very strong Vma Ϫ phenotype and no vacuolar acidification. Similar results were reported recently by Davis-Kaplan et al. (11) as the result of a genome-wide screen for mutants defective in iron-dependent growth. Here we provide evidence that the cwh36⌬ mutation disrupts an open reading frame encoding a yeast homolog of the M. sexta and bovine e subunits. This protein is essential for V-ATPase activity and copurifies with the V-ATPase from vacuolar membranes. Based on these results, this protein, which we propose to call Vma9p, appears to be an essential subunit of the V-ATPase in yeast cells.
EXPERIMENTAL PROCEDURES
Yeast Strains and Materials-The BY4741 cwh36⌬::KanMX strain (MAT a his3-⌬1 leu2-⌬0 met15-⌬0 ura3-⌬0 cwh36⌬::KanMX) was from the collection of haploid yeast strains each deleted in a single nonessential gene as described by Shoemaker et al. (12) and purchased from Invitrogen. PCR amplifications were carried out using LA Taq polymerase purchased from Panvera. Restriction enzymes were purchased from New England Biolabs. DNA sequencing was done by the State University of New York Upstate DNA sequencing facility. Concanamycin A was obtained from Wako Biochemicals, and octyl-␤-Dglucopyranoside was from Calbiochem. Mouse anti-HA monoclonal antibody was purchased from Covance, and mouse anti-yeast alkaline * This work was supported by National Institutes of Health Grant R01 GM50322 (to P. M. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
‡ To whom correspondence should be addressed. phosphatase antibody was purchased from Molecular Probes. All other reagents were from Sigma.
Yeast strains were maintained on yeast extract/peptone/dextrose (YEPD) or supplemented minimal medium prepared as described previously (13) . Where indicated, YEPD medium was buffered to pH 5 or 7.5 with 50 mM sodium phosphate, 50 mM sodium or buffered to pH 7.5 with 50 mM MES, 50 mM MOPS when CaCl 2 was added.
Plasmid and Strain Constructions-A fragment of genomic DNA containing the CWH36 and YCL005W-A genes was amplified by PCR from genomic DNA using oligonucleotides 5Ј-CGGTGAACCACATA-AGTGTATGTGCACACGCG-3Ј (5Ј-flanking primer) and 5Ј-GAGC-CAATTGACCACCGCCTC-3Ј (3Ј-flanking primer). The PCR fragment was cleaved with BglII and HindIII and inserted into the BamHI and HindIII sites of pRS315 (14). Premature stop sites were introduced into the CWH36 and YCL005W-A open reading frames by fusion PCR. To generate the early stop site of Cwh36p, two fragments were amplified using the following oligonucleotides (mutations are underlined): 1) 5Ј-GGCCCACATTAAAAACATCATGGCCAATGTC-3Ј and the 3Ј-flanking primer and 2) 5Ј-GGCCATGATGTTTTTAATGTGGGCCATTACG-3Ј and the 5Ј-flanking primer. The two fragments were then purified and combined, and the mutated fragment was obtained by fusion PCR using the two flanking primers. The premature stop codon in YCL005W-A was introduced by the same method except that the primer pairs for the first PCR reaction were the following: 1) 5Ј-GCTTGGTTGTTCTATG-GAGCCATTATCCAGAAC-3Ј and the 3Ј-flanking primer and 2) 5Ј-GGATAATGGCTCCATAGAACAACCAAGCGTATG-3Ј and the 5Ј-flanking primer. Both mutations were confirmed by DNA sequencing and cloned into vector pRS315 as described above.
The 3HA epitope tag was inserted at the C terminus of Vma9p as described by Wach (15) . The following three fragments were amplified by PCR. 1) The sequence encoding the VMA9 ORF was amplified from genomic DNA using oligonucleotides 5Ј-GAGAAGGCGCTGGTGTT-TCG-3Ј (VMA9 5Ј-flanking primer) and 5Ј-CCCGGGGATCCGTTCGT-CAAATTCAGGTCCAAATC-3Ј, 2) a fragment containing the 3HA epitope and a KanMX genetic marker was amplified from plasmid pFA6a-3HA-KanMX6 (16) using oligonucleotides 5Ј-CGGATC-CCCGGGTTAATTAA-3Ј (F2) and 5Ј-GAATTCGAGCTCGTTTAAAC-3Ј (R1), and 3) the sequence just downstream of the VMA9 stop codon was amplified from genomic DNA using oligonucleotides 5Ј-GAGCTCGAAT-TCAGCGTCGAGTATATCAAGCCAAG-3Ј and the CWH36 5Ј-flanking primer described above. The underlined portions of fragments 1 and 3 are complementary to portions of fragment 2, and these sequences supported fusion of the three purified fragments after they were combined and PCR-amplified in the presence of the two flanking primers. The product of the fusion PCR was used to transform SF838-1D␣ cells (MAT␣ leu2-112 ura3-52 his4-519 ade6 gal2 pep4-3) (17) . Transformants were selected by their growth on YEPD plates containing 200 g/ml G418. Insertion of the 3HA tag immediately before the VMA9 stop codon at the VMA9 genomic locus was confirmed by PCR from genomic DNA of the transformants and DNA sequencing. The vma2⌬::LEU2 and vma3⌬::URA3 alleles were introduced by PCR amplification of the mutant alleles followed by transformation into the epitope-tagged strain as described previously (18) .
Biochemical and Immunological Methods-Vacuoles were purified by Ficoll flotation as described by Roberts et al. (19) and resuspended in 15 mM MES, pH 7, 4.8% glycerol buffer. Concanamycin A-sensitive ATPase activity was assayed by a coupled enzyme assay (20) performed in the absence and presence of 200 nM concanamycin A. Protein concentrations were determined by Lowry assay (21). Western blot analysis of vacuolar vesicles and whole cell lysates was performed as described previously (22) using mouse monoclonal antibodies 8B1, 13D11, and 10D7, monoclonal antibodies against the A, B, and a subunits, respectively, of the V-ATPase; monoclonal antibody 1D3 against yeast alkaline phosphatase; and monoclonal antibody HA.11 against the 3HA epitope. Immunoprecipitation of the V-ATPase complex was performed as described by Parra and Kane (23) with the following exceptions. Vacuoles were solubilized in 2% octyl-␤-D-glucopyranoside 0.35% of the same detergent was included throughout the immunoprecipitation, and V-ATPase complexes were immunoprecipitated with the anti-B subunit antibody (13D11). Glycerol gradient purification of the V-ATPase was performed as described previously (24) with the following modifications. 1) Washed vacuolar vesicles were resuspended at a concentration of 5 mg/ml protein and solubilized in 2% octyl-␤-D-glucopyranoside. 2) A 7.8-ml glycerol step gradient, consisting of equal volume steps varying by 5% glycerol and covering a range of 50 -20% glycerol, was prepared in a 16 ϫ 60-mm Beckman Ultracentrifuge tube. All of the glycerol solutions contained 10 mM Tris, pH 7.5, 1 mM EDTA, and 0.35% octyl-␤-D-glucopyranoside. The solubilized vesicles were loaded on top of the gradient and then spun at 42,000 rpm for 7 h in a Beckman 70.1 Ti rotor. Fractions were collected from the bottom of the tube, precipitated by addition of trichloroacetic acid to a 10% final concentration, and then solubilized and visualized by immunoblotting as described.
RESULTS
A screen for vma mutants was performed on a library of yeast mutants deleted for each of the non-essential genes to discern genes that might affect V-ATPase activity. Screening revealed a number of mutants that had Vma Ϫ growth phenotypes, 2 including cwh36⌬ (YCL007c⌬). Vacuoles isolated from this deletion strain had a very low V-ATPase activity, suggesting a role for this gene in V-ATPase function.
2 Similar observations were also made by Davis-Kaplan et al. (11) starting from a genomic screen for yeast mutants defective in irondependent growth (11) .
To investigate the role of this protein in V-ATPase function, C-terminal HA, Myc, and green fluorescent protein epitope tags were fused to the CWH36 ORF (15, 16) . However, no tagged protein was expressed in any of the isolates screened. Kellis et al. (25) suggested that the CWH36 ORF overlapped with another, previously unidentified gene on the complement strand (YCL005W-A). The cwh36⌬ mutation would also delete most of this gene, and we hypothesized that deletion of this gene may have led to Vma Ϫ phenotype of the cwh36⌬ strain. Fig. 1A shows the genome position of the two genes.
The YCL005W-A ORF encodes a small hydrophobic protein of 8.4 kDa. Comparison of the primary sequence with data bases revealed homology to putative hydrophobic V-ATPase subunits in other organisms, including the M. sexta 9.7-kDa subunit e (9) and the human 9.2-kDa subunit, which is closely related to the bovine chromaffin granule 9.2-kDa protein. Fig.  1B shows a representative comparison of some of these genes with the yeast protein predicted from the YCL005W-A sequence. The yeast protein shows 25% identity to the M. sexta e subunit and 22% identity to the human, Drosophila, and Caenorhabditis elegans proteins. The CDART program (26) recognizes related proteins by domain architecture and groups the M. sexta and bovine e subunits with 26 other proteins from many different eukaryotes; when presented to the CDART program, the yeast YCL005W-A ORF was grouped with these proteins. 3 To clarify the role that Cwh36p or YCL005W-A protein may have in V-ATPase function, a complementation assay was performed. A fragment encompassing both genes was cloned into a low copy number plasmid and shown to complement the cwh36⌬ mutation as demonstrated by restored growth of the transformed cells on YEPD, pH 7.5 ϩ CaCl 2 medium (Fig. 1C ). Premature stop codons were then introduced into both reading frames, with the stop codon chosen to give no change in amino acid sequence for the gene on the opposite strand. (The positions of the stop codons are shown in Fig. 1A) . The mutant plasmids were transformed into a cwh36⌬ strain. The plasmid with the mutation predicted to truncate Cwh36p still permits growth of the mutant on YEPD, pH 7.5 and YEPD, pH 7.5 ϩ CaCl 2 medium, indicating that loss of Cwh36p does not affect function (Fig. 1C) . The plasmid with the mutation predicted to truncate the YCL005W-A ORF does not complement the cwh36⌬ mutant phenotype. These data indicate that the Vma TM   /  EBI accession numbers: CAE74051, EAA55854, XP_088142, CAE45916,  CAE02898, XP_313345, XP_313344, EAA38504, CAD27522, NP_649327,  NP_647882, NP_650578, BAC05292, NP_647868, AAK67647,  NP_446030, NP_598525, NP_568823, AAL48783, NP_501636,  NP_194401, AAK28556, NP_079548, AAF71753, NP_003936, CAA06822,  P81103 , and CAA75570.
Vma9p Is the Yeast V-ATPase e Subunit
mutant phenotype of the cwh36⌬ mutant arises from deletion of YCL005W-A, not CWH36. Based on this information and data described below we propose to rename YCL005W-A as VMA9.
To track this putative subunit and compare the effects of a V 1 or V 0 deletion on subunit localization, the gene was epitopetagged at the C terminus with three copies of the influenza hemagglutinin epitope in a vacuolar protease-deficient strain (pep4 mutant; Ref. 27 ). (We were unable to detect the tag when it was introduced into a PEP4 wild-type strain.) The strain containing the epitope-tagged Vma9p-3HA grew as well as the wild-type strain on YEPD, pH 7.5 ϩ CaCl 2 medium (data not shown). Vacuolar vesicles from the tagged strain had a concanamycin A-sensitive ATPase activity of 0.40 Ϯ 0.07 mol min Ϫ1 mg Ϫ1 (n ϭ 2), 53% of the activity obtained from the congenic wild-type strain. Western blots of the vacuolar vesicles were probed with antibodies to the HA epitope ( Fig. 2A) . Vacuoles from the VMA9-3HA-containing strain contain a cross-reacting band of ϳ15 kDa that is not found in the untagged strain. (The predicted size of Vma9p from the sequence is 8.4 kDa, and the 3HA tag has a predicted molecular mass of 4.8 kDa.) These data indicate that introduction of the 3HA tag into VMA9 does not prevent V-ATPase function and that Vma9p is found at the vacuole.
Previous studies have demonstrated that deletion of a V 1 subunit results in concurrent loss of other V 1 subunits from the 3) is diagrammed as described at the Saccharomyces Genome Database (www.yeastgenome.org). YCL005W-A has two introns at the indicated positions in the ORF (11, 25) . The cwh36⌬ mutation cleanly deletes the CWH36 ORF, from the start to the stop codon, and replaces the ORF with the KanMX marker. B, multisequence alignment of yeast YCL005W-A (GenBank TM /EBI accession number NC001135) with homologs in four other organisms, M. sexta (GenBank™/EBI accession number CAA06822), human (GenBank TM /EBI accession number CAA06822), C. elegans (GenBank TM /EBI accession number CAE45916), and Drosophila melanogaster (GenBank TM /EBI accession number AAF55365). Alignment was performed using the program CLUSTALW 1.8 (29) . Identical and conserved amino acids are highlighted in black and gray, respectively, using the program Multiple Align Show (30) . The two transmembrane domains predicted for the yeast YCL005W-A sequence by the Saccharomyces Genome Database are underlined. C, pH-dependent growth of cwh36⌬ and a VMA9 truncation mutant. The growth of wild-type cells (5A␣), the congenic cwh36⌬ deletion mutant (cwh36⌬), and the cwh36⌬ mutant carrying a series of low copy plasmids is compared. The plasmids used to transform the cwh36⌬ mutant include: the vector only (pRS315), the vector carrying a fragment containing the entire CWH36 and VMA9 ORFs (pRS315-CWH36/VMA9), and the pRS315-CWH36/VMA9 plasmid with early stop codons introduced into the CWH36 ORF (pRS315-cwh36 ES) or the VMA9 ORF (pRS315-vma9 ES). Both of the early stop (ES) mutations were designed so that the protein coded by the gene on the opposite strand was not changed. Growth of the cells was compared on YEPD medium buffered to pH 5, YEPD buffered to pH 7.5, and YEPD buffered to pH 7.5 containing 100 mM CaCl 2 .
vacuole, and deletion of a V 0 subunit leads to a decrease in all V-ATPase subunits at the vacuole (22) . To determine the effects of loss of V 1 and V 0 subunits on localization of Vma9p, we introduced a vma2⌬ mutation, which deletes the V 1 B subunit, or a vma3⌬ mutation, which deletes the V 0 c subunit, into the VMA9-3HA strain. Isolated vacuoles from these strains had no V-ATPase activity, characteristic of these deletion strains (data not shown). Western analysis ( Fig. 2A) confirmed that in the absence of an intact V 1 (vma2⌬ strain), the HA-tagged protein was still present at the vacuole. However, in the absence of V 0 (vma3⌬ strain), there was a clear decrease in this protein. In all strains, relative concentrations of the vacuolar protein alkaline phosphatase were the same ( Fig.  2A) . Western analysis of whole cell lysates showed little difference in relative subunit concentrations between strains (Fig. 2B) , except that the V 0 a subunit is at very low levels in the vma3⌬ strain (22) .
The results described above demonstrate that Vma9p is a vacuolar protein and that its presence in the vacuole is dependent on the presence of an intact V 0 sector. To test whether Vma9p is actually a subunit of the V-ATPase, we isolated V-ATPase complexes by two different methods. First, we solubilized vacuolar membranes and immunoprecipitated assembled V-ATPase complexes using an antibody to the V 1 subunit B. Immunoprecipitates from the Vma9p-3HA strain contain the ϳ15-kDa HA-tagged Vma9p, in addition to the 100-kDa V 0 subunit a and the 69-kDa V 1 subunit A, but immunoprecipitates from the untagged strain or from a mock precipitation 1, 3, and 4) or the strain containing Vma9p-3HA (lanes 2, 5, 6, and 7) . 10% of the solubilized vesicles used for immunoprecipitation were loaded directly in lanes 1 and 2. Lanes 3 and 5 represent the protein precipitated by addition of protein A-Sepharose beads to solubilized vacuolar vesicles without the addition of antibody. Lanes 4 and 6 represent the proteins immunoprecipitated from solubilized vacuolar vesicles by addition of antibody 13D11 against V 1 subunit B, followed by protein A-Sepharose. In lane 7, a comparable amount of antibody to that used in lanes 4 and 6 was incubated with protein A-Sepharose without any vesicles. All samples were solubilized, and 20% of the immunoprecipitated material was separated by SDS-PAGE and transferred to nitrocellulose as described under "Experimental Procedures." The immunoblot was then incubated with a mixture of antibodies against V 0 subunit a, V 1 subunit A, and HA. HC and LC indicate the heavy and light chains of the precipitating antibody. lacking any vacuolar membranes contain little or no HA-tagged protein (Fig. 3A) . Vacuoles from a vma2⌬ strain contain assembled V 0 sectors even though they lack V 1 subunits (23). To confirm that Vma9p is associated with the V 0 sector of the V-ATPase, we performed a similar immunoprecipitation from the vma2⌬ vacuoles containing HA-tagged Vma9p, in this case using an antibody to V 0 subunit a that is capable of immunoprecipitating free V 0 sectors (23) . As shown in Fig. 3B , the anti-a subunit antibody coprecipitates Vma9p-3HA from these vacuoles. In addition, glycerol gradient analysis of solubilized vacuoles was used to determine whether the tagged subunit fractionated with the assembled V-ATPase complex. Fig. 3C shows an immunoblot of fractions 2-14 of the glycerol gradient. As described previously (24) , the V 1 V 0 complex migrated to a glycerol concentration of ϳ35% (fraction 7), and the V 1 subunits (A and B) peaked at this position. V 0 subunit a is also present in this fraction but shows a somewhat broader distribution through fractions 6 -10. Like the V 0 a subunit, Vma9p-3HA was present in fraction 7 with the intact V 1 V 0 complexes but was also found in fractions 6 -10. All of the subunits were also at the top of the gradient, in fractions 13-14; these fractions may include free V 0 sectors as well as disassembled or unsolubilized complexes. Taken together, these data indicate that Vma9p is part of assembled V 1 V 0 complexes and free V 0 complexes.
DISCUSSION
Taken together, the data presented here provide strong evidence that Vma9p is a V-ATPase subunit. First, disruption of the VMA9 gene results in a characteristic Vma Ϫ phenotype (Fig. 1) , loss of vacuolar acidification (11), 2 and loss of VATPase activity at the vacuole. 2 Second, Vma9p is present at the vacuole, and its vacuolar localization is dependent on the presence of other V 0 subunits (Fig. 2) . Third, Vma9p is assembled with the V-ATPase at the vacuolar membrane (Fig. 3) . Biochemical studies demonstrating association of homologous proteins with the M. sexta and bovine V-ATPases had suggested these proteins were subunits (8, 9) but left open the possibility that they might be tissue-specific and provided no test of their significance in V-ATPase function. In contrast, the previously characterized yeast Vma21p is essential for V-ATPase function, based on the Vma Ϫ phenotype of vma21⌬ mutants, but is not part of the final assembled V-ATPase complex (10) . Significantly, the VMA21 gene showed some homology to the mammalian e subunit genes (8) but little or no homology to the M. sexta and yeast genes, and it was not grouped with the e subunits by the CDART program (26) . The functional data presented here, along with the homology with the ϳ9-kDa V-ATPase-associated proteins from M. sexta and bovine cells (8, 9) and the presence of homologs in many different eukaryotes, suggest that the e subunit may play an essential role in all V-ATPases.
These results also predict certain features of this subunit that can be probed in future experiments. Analysis of the predicted amino acid sequence of YCL005W-A (Saccharomyces Genome Database; www.yeastgenome.org) suggests that Vma9p might have two transmembrane domains. This, along with the data indicating that its presence in the vacuole is dependent on the presence of an intact V 0 sector but not an intact V 1 sector, suggests that it is a V 0 sector subunit; coprecipitation of Vma9p-3HA with the V 0 sector from vma2⌬ vacuoles (Fig. 3B) provides strong evidence that it is indeed a V 0 sector subunit. Although we had never noticed an 8.4-kDa protein in previous purifications of the yeast V-ATPase, V 0 sectors immunoprecipitated from vacuolar membranes of a vma2⌬ mutant do contain a small molecular mass protein (23) that might be Vma9p. In addition, Ludwig et al. (8) noted previously that the chromaffin 9.2-kDa protein was difficult to visualize by SDS-PAGE. The apparent sensitivity of the Cterminal 3HA tag to vacuolar proteases in a Pep4 ϩ strain would suggest that the C terminus of the Vma9p might face the vacuolar lumen, and this is consistent with the topology proposed for the M. sexta e subunit, based on glycosylation of this protein at a site near the C terminus of the protein (8, 9) . It is also interesting that although Vma9p does not reach the vacuole in the vma3⌬ mutant, it is present at near wild-type levels in whole cell lysates of the mutant (Fig. 2B) . In contrast, the a subunit is rapidly degraded when one of the other V 0 subunits is missing. This suggests that proper assembly of V 0 sectors is not essential for Vma9p stability, but there is still a possibility that the 3HA tag is stabilizing Vma9p in our experiments. Finally, the position of the e subunit in the V 0 sector is an intriguing question. The e subunit appears to contain no intramembrane acidic residues, like the three essential c-like subunits of the yeast V 0 sector (28) , so it is unlikely that it directly participates in proton transport. Placement of the e subunit in the V 0 complex may provide further insights into its functional contribution.
